Simulated Surgery Rehearsal (MIPN)
Patient-specific Simulated Procedure Rehearsal for Minimally Invasive Surgery
1 other identifier
observational
70
1 country
1
Brief Summary
The purpose of the study is to evaluate patient-specific surgical simulation by permitting pre-operative rehearsals, in the form of the surgeon completing a dry run of the procedure on a model constructed from the patient's radiological studies that replicates every aspect of their organs. The investigators' aim is to evaluate the effectiveness of this form of practice in optimizing intraoperative and postoperative outcomes . The investigators hope eventually to use these rehearsals as a standard study tool for surgical training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedStudy Start
First participant enrolled
October 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedFebruary 10, 2023
February 1, 2023
5.3 years
May 10, 2017
February 8, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Warm ischemia time measured during minimal invasive partial nephrectomy surgery
Warm ischemia time is reported on completion of minimal invasive partial nephrectomy surgery, the metric will be measured in minutes as a continuous variable.
At the end of each surgical procedure, approximately 24 hours after surgery
Estimated blood loss measured during minimal invasive partial nephrectomy surgery
Estimated blood loss is reported on completion of minimal invasive partial nephrectomy surgery, it is estimated by the volume of fluid in the suction irrigation at the end of surgery and measured in ml as a continuous variable.
At the end of each surgical procedure, approximately 24 hours after surgery
Change in postoperative renal functions
The difference between preoperative (within a week prior to surgery) and postoperative (12 hours , 1 day and 30 days after surgery) using estimated GFR measured through serum creatinine blood test.
Zero at date of randomization and serial measurements at 12 hours , 1 day and 30 days after surgery
Surgical complications
Intraoperative and postoperative complications will be measured and reported using the modified Clavien-Dindo classification of surgical complications (Grade 1 to 5).
From date of surgery up to 30 days postoperative, every complication encountered during that time will be recorded
Objective evaluation of surgical performance
All surgical cases will be recorded and reviewed by a third party online tool that specializes in evaluation of surgical performance using the GEARS (Global Evaluative Assessment of Robotic Skills) tool
At the end of each surgical procedure, approximately 24 hours after surgery
Operative time measured during minimal invasive partial nephrectomy surgery
Operative time is reported on completion of minimal invasive partial
At the end of each surgical procedure, approximately 24 hours after surgery
Secondary Outcomes (4)
Positive margins of the tumor specimen
From date of randomization up to 10 days after surgery
Change in the volume of ratio of red blood cells to total blood volume (HCT)
Zero at date of randomization and serial measurements at 12 and 24 hours after surgery
Hospital stay
From date of admission up to 30 days after surgery
Hospital readmission
From date of surgery up to 30 days postoperative, every hospital readmission encountered during that time will be recorded
Study Arms (2)
Physical reality simulation (rehearsal)
Using 3-D printing and polymer technology, the investigators will construct patient specific simulated hydrogel models designed from patients' imaging, incorporating the necessary anatomy, physiology and pathology specific to each patient. Participants with patients assigned to preoperative rehearsal will undergo pre-operative simulation only once.
Virtual reality simulation
The DaVinci surgical skills simulator (DVSSS) uses a virtual reality surgical simulation platform that encompasses a variety of basic exercises specifically designed to give users the opportunity to improve their proficiency with the da Vinci surgeon console controls and basic robotic surgical skills. Participants with patients assigned to preoperative simulation will complete a refresher module on the Virtual reality simulator.
Interventions
Using 3-D printing and polymer technology, the investigators will construct patient specific simulated hydrogel models designed from patients' imaging, incorporating the necessary anatomy, physiology and pathology specific to each patient. These models are constructed at the Laboratory for Simulation-based Translational Research at the Department of Urology. Group 1 urologists will rehearse the minimally-invasive partial nephrectomy (MIPN) surgery using these patient-specific models.
The DaVinci surgical skills simulator system uses a virtual reality surgical simulation platform that encompasses a variety of basic exercises specifically designed to give users the opportunity to improve their proficiency with the da Vinci surgeon console controls and basic robotic surgical skills. All urologists have already completed a basic robotic skills curriculum. Group 2 urologists will complete a refresher module on the virtual reality simulator.
Eligibility Criteria
Study population is comprised of 100 minimally invasive partial nephrectomy (MIPN) patients), 5 faculty expert urologists, and 5 trainees including four urology residents and one endourology fellow.
You may qualify if:
- All patients scheduled to undergo MIPN surgery at the University of Rochester Medical Center
- Ability to give informed consent
- Willing to participate in the study
- Any racial or ethnic origin
You may not qualify if:
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester Medical Center
Rochester, New York, 14642, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Ghazi, MD
University of Rochester
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 10, 2017
First Posted
May 16, 2017
Study Start
October 12, 2017
Primary Completion
January 31, 2023
Study Completion
January 31, 2023
Last Updated
February 10, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share